Amedeo Smart

Free Medical Literature Service


 

Amedeo

Diabetes

  Free Subscription

Articles published in
Am J Nephrol
    May 2024
  1. MOLONEY BM, Chertow GM, Mc Causland FR
    Association of Diabetes with Changes in Blood Pressure during Hemodialysis: A Secondary Analysis of the Frequent Hemodialysis Network Daily Trial.
    Am J Nephrol. 2024 May 23. doi: 10.1159/000539451.
    >> Share

    February 2024
  2. STAVAS J, Silva AL, Wooldridge TD, Aqeel A, et al
    Rilparencel (Renal Autologous Cell Therapy-REACT(R)) for Chronic Kidney Disease and Type 1 and 2 Diabetes: Phase 2 Trial Design Evaluating Bilateral Kidney Dosing and Re-Dosing Triggers.
    Am J Nephrol. 2024 Feb 29. doi: 10.1159/000537942.
    >> Share

    January 2024
  3. TUTTLE KR, Rossing P, Hauske SJ, Cronin L, et al
    Methods Article for a Study Protocol: Study Design and Baseline Characteristics for Aldosterone Synthase Inhibition in Chronic Kidney Disease.
    Am J Nephrol. 2024;55:262-272.
    >> Share

    November 2023
  4. GAO LQ, Xue CC, Cui J, Xu J, et al
    Diabetic Retinopathy and Chronic Kidney Disease: Associations and Comorbidities in a Large Diabetic Population: The Tongren Health Care Study.
    Am J Nephrol. 2023 Nov 10. doi: 10.1159/000535059.
    >> Share

    October 2023
  5. CHUANG GT, Kremer D, Huang CH, Alkaff FF, et al
    Urinary Fetuin-A Fragments Predict Progressive eGFR Decline in Two Independent Type 2 Diabetes Cohorts of Different Ethnicities.
    Am J Nephrol. 2023 Oct 9. doi: 10.1159/000534514.
    >> Share

  6. TSAI HL, Lin TC, Lin NC, Yang HH, et al
    Risk factors for fractures in renal transplantation: a population-based cohort study.
    Am J Nephrol. 2023 Oct 2. doi: 10.1159/000533125.
    >> Share

    September 2023
  7. CHINNADURAI R, Rengarajan S, Budden JJ, Quinn CM, et al
    Maintaining renin-angiotensin-aldosterone system inhibitor treatment with patiromer in hyperkalaemic chronic kidney disease patients: comparison of a propensity-matched real-world population with AMETHYST-DN.
    Am J Nephrol. 2023 Sep 19. doi: 10.1159/000533753.
    >> Share

  8. KOYA D, Anker SD, Ruilope LM, Rossing P, et al
    Cardiorenal Outcomes with Finerenone in Asian Patients with Chronic Kidney Disease and Type 2 Diabetes: A FIDELIO-DKD post hoc Analysis.
    Am J Nephrol. 2023 Sep 14:1-9. doi: 10.1159/000532102.
    >> Share

    July 2023
  9. YANG WS, Chuang GT, Che TP, Chueh LY, et al
    Genome-Wide Association Studies for Albuminuria of non-Diabetic Taiwanese Population.
    Am J Nephrol. 2023 Jul 12. doi: 10.1159/000531783.
    >> Share

    May 2023
  10. LI X, Qureshi AR, Suliman ME, Heimburger O, et al
    Interleukin-6 to albumin ratio as a superior predictor of mortality in end stage kidney disease patients.
    Am J Nephrol. 2023 May 24. doi: 10.1159/000531191.
    >> Share

  11. XIAO Y, Xiao Z
    Association between serum Klotho and kidney stones in US middle-aged and older individuals with diabetes mellitus: Results from 2007-2016 National Health and Nutrition Survey.
    Am J Nephrol. 2023 May 15:1. doi: 10.1159/000531045.
    >> Share

    March 2023
  12. SINGH AP, Kalil R, Weir MR
    Role of Sodium-Glucose Cotransporter 2 inhibitors for management of diabetes mellitus in renal transplant recipients; and management strategies for post-transplant hypertension.
    Am J Nephrol. 2023 Mar 24. doi: 10.1159/000530296.
    >> Share

  13. RIZK JG, Hsiung JT, Arif Y, Hashemi L, et al
    Triglycerides and Renal Outcomes according to Albuminuria and in Consideration of other Metabolic Syndrome Components in Diabetic US Veterans.
    Am J Nephrol. 2023 Mar 8. doi: 10.1159/000529414.
    >> Share

    February 2023
  14. TUTTLE KR, Wilson JM, Lin Y, Qian HR, et al
    Indicators of Kidney Fibrosis in Patients With Type 2 Diabetes and Chronic Kidney Disease Treated With Dulaglutide.
    Am J Nephrol. 2023 Feb 8. doi: 10.1159/000529374.
    >> Share

    January 2023
  15. MENDE CW, Samarakoon R, Higgins PJ
    [Mineralocorticoid receptor (MR)-associated mechanisms in diabetic kidney disease and clinical significance of MR antagonists].
    Am J Nephrol. 2023 Jan 20. doi: 10.1159/000528783.
    >> Share

  16. CHEN TK, Coca SG, Thiessen-Philbrook HR, Heerspink HJL, et al
    [Urinary Biomarkers of Tubular Health and Risk for Kidney Function Decline or Mortality in Diabetes].
    Am J Nephrol. 2023 Jan 11. doi: 10.1159/000528918.
    >> Share

    December 2022
  17. CHIU V, Gross AL, Chu NM, Segev D, et al
    Domains for a Comprehensive Geriatric Assessment of Older Adults with Chronic Kidney Disease: Results from the CRIC Study.
    Am J Nephrol. 2022 Dec 9. doi: 10.1159/000528602.
    >> Share

    September 2022
  18. GRUPPER A, Rabinowich A, Ben Shabat I, Tzadok R, et al
    Nonalcoholic Fatty Liver Disease before Kidney Transplantation Correlates with New Onset Diabetes and Poor Metabolic Outcomes.
    Am J Nephrol. 2022 Sep 8:1-10. doi: 10.1159/000526118.
    >> Share

    June 2022
  19. THEOFILIS P, Vordoni A, Kalaitzidis RG
    The Role of Melatonin in Chronic Kidney Disease and Its Associated Risk Factors: A New Tool in Our Arsenal?
    Am J Nephrol. 2022 Jun 29:1-10. doi: 10.1159/000525441.
    >> Share

    February 2022
  20. ZHANG J, Fuhrer T, Ye H, Kwan B, et al
    High-Throughput Metabolomics and Diabetic Kidney Disease Progression: Evidence from the Chronic Renal Insufficiency (CRIC) Study.
    Am J Nephrol. 2022 Feb 23:1-11. doi: 10.1159/000521940.
    >> Share

    January 2022
  21. STAVAS J, Gerber D, Coca SG, Silva AL, et al
    Novel Renal Autologous Cell Therapy for Type 2 Diabetes Mellitus Chronic Diabetic Kidney Disease: Clinical Trial Design.
    Am J Nephrol. 2022 Jan 14:1-9. doi: 10.1159/000520231.
    >> Share

  22. LAM D, Nadkarni GN, Mosoyan G, Neal B, et al
    Clinical Utility of KidneyIntelX in Early Stages of Diabetic Kidney Disease in the CANVAS Trial.
    Am J Nephrol. 2022 Jan 11:1-11. doi: 10.1159/000519920.
    >> Share

  23. SUZUKI Y, Kaneko H, Okada A, Itoh H, et al
    Impact of Glucose Tolerance and Its Change on Incident Proteinuria: Analysis of a Nationwide Population-Based Dataset.
    Am J Nephrol. 2022;53:307-315.
    >> Share

  24. CHERNEY DZI, Cosentino F, Dagogo-Jack S, McGuire DK, et al
    Initial eGFR Changes with Ertugliflozin and Associations with Clinical Parameters: Analyses from the VERTIS CV Trial.
    Am J Nephrol. 2022;53:516-525.
    >> Share

    December 2021
  25. FERREIRA JP, Rossignol P, Bakris G, Mehta C, et al
    Blood and Urine Biomarkers Predicting Worsening Kidney Function in Patients with Type 2 Diabetes Post-Acute Coronary Syndrome: An Analysis from the EXAMINE Trial.
    Am J Nephrol. 2021 Dec 6:1-8. doi: 10.1159/000519436.
    >> Share

    March 2021
  26. CHO ME, Sweeney C, Fino N, Greene T, et al
    Longitudinal Changes in Prorenin and Renin in the Chronic Renal Insufficiency Cohort.
    Am J Nephrol. 2021 Mar 18:1-11. doi: 10.1159/000514302.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016